<DOC>
	<DOCNO>NCT01130571</DOCNO>
	<brief_summary>Xenografts cell culture provide sufficient material analysis protein , RNA DNA level . Patient derive NSCLC xenograft cell line available none however Asian origin . Given emerge evidence suggest inter-ethnic difference NSCLC biology , new model preclinical drug evaluation design validate use Asian tumor . Furthermore , model allow study biological mechanism sensitivity and/or resistance also study dynamic regulation standardize condition Asian context .</brief_summary>
	<brief_title>Establishment Characterization Patient-Derived Non-Small Cell Lung Cancer Xenografts Cell Cultures</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Patients age 21 year . Undergoing surgical resection tumor part clinical management Patient legally acceptable representative unable provide consent patient judgement study investigator , medically unsuitable study</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>